Comments and Reply on: Study of multi-muon events produced in pp interactions at √s = 1.96 TeV; T. Aaltonen et al. (The CDF Collaboration)

APOLLINARI, G ; APRESYAN, A ; BEHARI, S ; BELLETTINI, G ; BENJAMIN, D ; BISELLO, D ; BIZJAK, I ; BLOCKER, C ; BLUMENFELD, B ; BOCCI, A ; BOISVERT, V ; BOLLA, G ; ARISAWA, T ; BORTOLETTO, D ; BOUDREAU, J ; BRIDGEMAN, A ; BRIGLIADORI, L ; BROMBERG, C ; BRUBAKER, E ; BUDAGOV, J ; BUDD, H. S ; BUDD, S ; BURKE, S ; ARTIKOV, A ; BURKETT, K ; BUSETTO, G ; BUSSEY, P ; BYRUM, K. L ; CABRERA, S ; CALANCHA, C ; CAMPANELLI, M ; CANELLI, F ; CARLS, B ; CAROSI, R ; ASHMANSKAS, W ; CARRILLO, S ; CASAL, B ; CASARSA, M ; CASTRO, A ; CATASTINI, P ; CAUZ, D ; CAVALIERE, V ; CHANG, S. H ; CHEN, Y. C ; CHERTOK, M ; AZZURRI, P ; CHIARELLI, G ; CHLACHIDZE, G ; CHO, K ; CHOKHELI, D ; CHOU, J. P ; CHUNG, K ; CHUNG, Y. S ; CIOBANU, C. I ; CIOCCI, M. A ; CLARK, A ; BADGETT, W ; BARNETT, B. A ; BARTSCH, V ; BEECHER, D

Heidelberg: Springer

Texto completo disponível

Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study

Motzer, R. ; Porta, C. ; Alekseev, B. ; Rha, S. Y. ; Choueiri, T. K. ; Mendez-Vidal, M. J. ; Hong, S. H. ; Kapoor, A. ; Goh, J. C. ; Eto, M. ; Bennett, L. ; Wang, J. ; Pan, J. J. ; Saretsky, T. L. ; Perini, R. F. ; He, C. S. ; Mody, K. ; Cella, D.

Texto completo disponível